Tulane Cancer Center
Announces Participation
in Major Prostate Cancer Prevention Trial:
Selenium and Vitamin E Cancer Prevention Trial (SELECT)
(SWOG 0000)
Closed to accrual June 2004
WHAT:
Research study involving over 600 men locally (over 32,000 men nationally) to find out if taking selenium and/or vitamin E supplements can prevent prostate cancer.
WHY:
Prostate cancer is the most common type of cancer, after skin cancer, amongen in the United States and Canada. Selenium and vitamin E are anti-oxidants. It is believed that they help control the cell damage that can lead to cancer. Two studies that looked at preventing other cancers suggested that selenium and vitamin E might prevent prostate cancer. SELECT is the first study to look directly at the effect of selenium and/or vitamin E on the risk of prostate cancer.
WHO:
Men may be able to participate in SELECT
if they are 55 years of age or older, or an African-American age 50 or older.
This age difference is because prostate cancer appears at younger ages in African-American men than in men of other ethnic groups.
if they have never had prostate cancer
if they have not had any other cancer for the last five years (except skin cancer).
if they are in generally good health.
HOW:
Men who are interested in participating in SELECT are invited to schedule an educational information session with the Tulane Cancer Center. The educational sessions will cover a variety of information ranging from eligibility criteria to financial issues.
Please contact the Tulane Cancer Center's Office of Clinical Research at (504) 988-6450 or (504) 988-6121 to register for a session.
See also: